Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Gastrointestinal Stromal Tumor
This book provides a comprehensive and up-to-date overview of gastrointestinal stromal tumors (GISTs). GISTs represent the most common mesenchymal neoplasms arising within the gastrointestinal tract. The causative gene of this disease was originally discovered in Japan by Prof. Seichi Hirota in 1998, and since then numerous important advances – from basic to clinical aspects – have been reported from Japan. Professionals involved in the management of GISTs inevitably cite significant evidence and the state-of-the-art treatments from the Asian region, where has there is and inherently high prevalence of gastrointestinal cancers. Each expert author elucidates the cutting-edge knowledge on pathophysiology, diagnosis, and treatment of GISTs, especially focusing on the highly valuable data from Japan. This attractive collection benefits not only oncologists but also basic researchers, general physicians and surgeons, as well as paramedical staff and medical students who are dealing with GISTs.
Clinical metagenomics-based diagnostics for infectious diseases
Clinical metagenomics is an emerging method in the diagnosis of infectious diseases that uses next generation sequencing (NGS) technology to identify the etiologic agents to allow for more effective and targeted treatment of infectious diseases. Conventional diagnostic methods are mainly based on basic morphologic, phenotypic and genotypic analyses which can be insensitive and/or time consuming. Metagenomic NGS (mNGS) can be performed with only a small amount of nucleic acid from the specimen and not only can the pathogen be identified and characterized, but also its antimicrobial susceptibility can be inferred. Although tremendous advancements were made in the speed, throughput, and cost of NGS in recent years, the application of clinical metagenomics in routine diagnosis of infectious diseases is not yet practical because of its much higher cost compared to conventional microbiological tests, complex laboratory workflows and computational challenges.
Official Gazette
None
